Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia

Completed · Phase 4

Conditions studied: Schizophrenia

In brief

The purpose of this study is to determine how Olanzapine compares to an active comparator in the treatment of schizophrenia

Key facts

Study ID

NCT00036088

Run by

Eli Lilly and Company

People needed

530

Starts

2001-08-01

Expected to finish

2002-07-01

Last updated by the study team

2006-07-19

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

Where it is running

• Study site — Glendale, California, United States
• Study site — Sherman Oaks, California, United States
• Study site — Middleton, Connecticut, United States
• Study site — Norwich, Connecticut, United States
• Study site — Melbourne, Florida, United States
• Study site — Miami, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Hoffman Estates, Illinois, United States
• Study site — Lafayette, Indiana, United States
• Study site — Rockville, Maryland, United States
• Study site — Newton, Massachusetts, United States
• Study site — Saint Charles, Missouri, United States
• Study site — New York, New York, United States
• Study site — Olean, New York, United States
• Study site — Staten Island, New York, United States
• Study site — Cincinnati, Ohio, United States
• Study site — Portland, Oregon, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Austin, Texas, United States
• Study site — El Paso, Texas, United States
• Study site — Houston, Texas, United States
• Study site — Terrell, Texas, United States
• Study site — Richmond, Virginia, United States
• Study site — El Centro, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.